CME Group Inc. (NASDAQ:CME) Relative Strength Index (RSI) is 62.01, with weekly volatility at 2.13% and ATR at 4.02. The CME stock’s 52-week price range has touched low of $144.85 and a $218.80 high. Intraday shares traded counted 0.9 million, which was 44.09% higher than its 30-day average trading volume of 1.61M. Its shares traded lower over the last trading session, losing -1.02% on 05/18/21. The shares fell to a low of $214.00 before closing at $214.23. CME’s previous close was $216.43 while the outstanding shares total 358.15M. The firm has a beta of 0.43, a 12-month trailing P/E ratio of 40.16, and a growth ratio of 8.01.
Investors have identified the Financial Data & Stock Exchanges company CME Group Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $76.32 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
CME Group Inc. (CME) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 126.75 billion total, with 124.22 billion as their total liabilities.
Having a look at the company’s valuation, the company is expected to record 7.20 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on CME sounds very interesting.
Is the stock of CME attractive?
In related news, Sr MD Chief Operating Officer, Holzrichter Julie sold 6,000 shares of the company’s stock in a transaction that recorded on May 12. The sale was performed at an average price of 213.29, for a total value of 1,279,740. As the sale deal closes, the Director, GEPSMAN MARTIN J now sold 1,500 shares of the company’s stock, valued at 308,190. Also, Sr MD & Chief HR Officer, Piell Hilda Harris sold 1,500 shares of the company’s stock in a deal that was recorded on Mar 05. The shares were price at an average price of 213.00 per share, with a total market value of 319,500. Following this completion of acquisition, the Sr MD Global Hd Financial & OT, Tully Sean now holds 10,000 shares of the company’s stock, valued at 2,014,050. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.20%.
8 out of 22 analysts covering the stock have rated it a Buy, while 10 have maintained a Hold recommendation on CME Group Inc.. 2 analysts has assigned a Sell rating on the CME stock. The 12-month mean consensus price target for the company’s shares has been set at $206.89.